The Association Between RAPSN Methylation in Peripheral Blood and Early Stage Lung Cancer Detected in Case–Control Cohort
暂无分享,去创建一个
Rongxi Yang | B. Han | R. Qiao | Jun Wang | Feifei Di | Wanjian Gu | Tian Xu | Yue Wang | Yujie Wei | Yan-mei Zhang
[1] H. Sasano,et al. Sex steroid metabolism and actions in non-small cell lung carcinoma , 2019, The Journal of Steroid Biochemistry and Molecular Biology.
[2] Yu Cao,et al. A mechanism in agrin signaling revealed by a prevalent Rapsyn mutation in congenital myasthenic syndrome , 2019, eLife.
[3] Michelle R. Campbell,et al. Smoking-associated AHRR demethylation in cord blood DNA: impact of CD235a+ nucleated red blood cells , 2019, Clinical Epigenetics.
[4] C. Ling,et al. Sex influences DNA methylation and gene expression in human skeletal muscle myoblasts and myotubes , 2019, Stem Cell Research & Therapy.
[5] F. Kadayifci,et al. Molecular Mechanisms Underlying the Link between Diet and DNA Methylation , 2018, International Journal of Molecular Sciences.
[6] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[7] Jacqueline A Palace,et al. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes , 2018, International journal of molecular sciences.
[8] Iaslc Staging,et al. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer , 2017 .
[9] P. Bugert,et al. HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study , 2017, Oncotarget.
[10] Xiaohui Ren,et al. DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma , 2017, Oncotarget.
[11] H. Leung,et al. Limb girdle myasthenia with digenic RAPSN and a novel disease gene AK9 mutations , 2017, European Journal of Human Genetics.
[12] T. Holland-Letz,et al. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA , 2016, Oncotarget.
[13] Kimberly Walter,et al. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications , 2016, Nature Biotechnology.
[14] Yao Lin,et al. Low Expression of CDK5 and p27 Are Associated with Poor Prognosis in Patients with Gastric Cancer , 2016, Journal of Cancer.
[15] D. Elliott,et al. Hallmarks of glycosylation in cancer , 2016, Oncotarget.
[16] V. Rusch,et al. Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer. , 2016, The Annals of thoracic surgery.
[17] E. Smit,et al. Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study. , 2015, Lung cancer.
[18] H. Brenner,et al. Smoking-Associated DNA Methylation Biomarkers and Their Predictive Value for All-Cause and Cardiovascular Mortality , 2015, Environmental health perspectives.
[19] Huan-ling Yu,et al. Global DNA methylation was changed by a maternal high-lipid, high-energy diet during gestation and lactation in male adult mice liver , 2015, British Journal of Nutrition.
[20] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[21] H. Brody. Lung cancer , 2014, Nature.
[22] Xintao Wei,et al. Genome-wide Identification of Zero Nucleotide Recursive Splicing in Drosophila , 2014, Nature.
[23] A. Karlsson,et al. The many isoforms of human adenylate kinases. , 2014, The international journal of biochemistry & cell biology.
[24] Jun Lu,et al. CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression , 2013, Scientific Reports.
[25] J. Issa,et al. Examination of Whole Blood DNA Methylation as a Potential Risk Marker for Gastric Cancer , 2013, Cancer Prevention Research.
[26] Christian Gieger,et al. Tobacco Smoking Leads to Extensive Genome-Wide Changes in DNA Methylation , 2013, PloS one.
[27] Paolo Vineis,et al. Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. , 2013, Human molecular genetics.
[28] T. Spector,et al. DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker , 2012, Carcinogenesis.
[29] S. Horvath,et al. Aging effects on DNA methylation modules in human brain and blood tissue , 2012, Genome Biology.
[30] J. Rosales,et al. Level of cdk5 expression predicts the survival of relapsed multiple myeloma patients , 2012, Cell cycle.
[31] Claire D. McWhite,et al. Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway , 2012, Molecular biology of the cell.
[32] P. Singh,et al. Cyclin-Dependent Kinase 5 Is Amplified and Overexpressed in Pancreatic Cancer and Activated by Mutant K-Ras , 2011, Clinical Cancer Research.
[33] T. Taguchi,et al. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation , 2011, Breast Cancer Research and Treatment.
[34] Margaret R Karagas,et al. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[36] A. Bird,et al. DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.
[37] J. Craigon,et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status , 2007, Proceedings of the National Academy of Sciences.
[38] Paul Cairns,et al. Gene methylation and early detection of genitourinary cancer: the road ahead , 2007, Nature Reviews Cancer.
[39] J. Palace,et al. Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations. , 2006, Brain : a journal of neurology.
[40] T. Perfetti,et al. Perspectives on Pulmonary Inflammation and Lung Cancer Risk in Cigarette Smokers , 2006, Inhalation toxicology.
[41] K. Ohno,et al. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine , 2004, Neuromuscular Disorders.
[42] R. Maselli,et al. Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering , 2003, Muscle & nerve.
[43] P. Laird. Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.
[44] Kinji Ohno,et al. Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. , 2002, American journal of human genetics.
[45] A. Wolffe,et al. DNA methylation in health and disease , 2000, Nature Reviews Genetics.
[46] J. Patrick,et al. The postsynaptic 43k protein clusters muscle nicotinic acetylcholine receptors in xenopus oocytes , 1990, Neuron.
[47] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[48] J. Crowley,et al. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[49] Shelly C. Lu,et al. Alcohol, DNA Methylation, and Cancer , 2013, Alcohol research : current reviews.
[50] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[51] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[52] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.